MEDP Medpace Holdings, Inc.
MEDP Medpace Holdings, Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $595.32 · VWAP $523.63 · +18.1% vs 12m avg buyer
Insiders selling 0 buy / 6 sell · Form 4, 90d $157.8M sold last open-market sell Troendle August J.
Cluster CEO, CFO + 3 others sold $51.5M, Aug 21–31
Coverage
1 related campaign
MEDP Price Structure
Loading timeframes…
Peers
Every watchlist MEDP belongs to, members best 30-day change first — MEDP highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Medpace's Q2 2026 print read as a beat: American Banking News (2026-07-28) reports the stock reaching a new 52-week high on "better-than-expected earnings," and MarketBeat (2026-07-28) logged price-target hikes to $609 (Truist, up from $462, Hold maintained) and $624 (Baird, Neutral maintained) in the print's wake.
full note →Against street estimates
How MEDP's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about MEDP from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 16
MEDP research tape
54 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to MEDP.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries